{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:29:44Z","timestamp":1793827784020,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100755"],"award-info":[{"award-number":["82100755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370747"],"award-info":[{"award-number":["82370747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.redox.2023.102946","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T12:23:06Z","timestamp":1698150186000},"page":"102946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"C","title":["Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K\/Akt\/eNOS signaling pathway in diabetic tubulopathy"],"prefix":"10.1016","volume":"68","author":[{"given":"Lan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangsuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8786-4378","authenticated-orcid":false,"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2023.102946_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.redox.2023.102946_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.redox.2023.102946_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155195","article-title":"Mitochondrial dysfunction in diabetic tubulopathy","volume":"131","author":"Yao","year":"2022","journal-title":"Metab., Clin. Exp."},{"key":"10.1016\/j.redox.2023.102946_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2337\/db16-0796","article-title":"Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease","volume":"66","author":"Gilbert","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2023.102946_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","article-title":"Mitochondria: in sickness and in health","volume":"148","author":"Nunnari","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.redox.2023.102946_bib6","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1681\/ASN.2014050457","article-title":"Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease","volume":"26","author":"Zhan","year":"2015","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.redox.2023.102946_bib7","doi-asserted-by":"crossref","first-page":"F767","DOI":"10.1152\/ajprenal.00565.2018","article-title":"Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy","volume":"317","author":"Lee","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2023.102946_bib8","first-page":"711","volume":"vol. 130","author":"Coughlan","year":"2016"},{"key":"10.1016\/j.redox.2023.102946_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/phar.2633","article-title":"Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI\/ARBs in patients with diabetic kidney disease","volume":"41","author":"An","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.redox.2023.102946_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/112_2020_50","article-title":"Potential of renin-angiotensin-aldosterone system modulations in diabetic kidney disease: old players to new hope! Reviews of physiology","volume":"179","author":"Malek","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2023.102946_bib11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ymthe.2021.10.013","article-title":"Kidney single-cell transcriptome profile reveals distinct response of proximal tubule cells to SGLT2i and ARB treatment in diabetic mice","volume":"30","author":"Wu","year":"2022","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.redox.2023.102946_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrneph.2010.32","article-title":"Diabetic nephropathy: aldosterone breakthrough in patients on an ACEI","volume":"6","author":"Nakagawa","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.redox.2023.102946_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.754239","article-title":"Mineralocorticoid receptor antagonists in diabetic kidney disease","volume":"12","author":"Kawanami","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2023.102946_bib14","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.102946_bib15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.120.051898","article-title":"Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes","volume":"143","author":"Filippatos","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2023.102946_bib16","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1152\/ajpendo.00022.2023","article-title":"Therapeutic perspective: evolving evidence of nonsteroidal mineralocorticoid receptor antagonists in diabetic kidney disease","volume":"324","author":"Yao","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.redox.2023.102946_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","article-title":"Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?","volume":"62","author":"Bender","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2023.102946_bib18","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1159\/000339500","article-title":"Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K\/MAPK signalling","volume":"120","author":"Huang","year":"2012","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.redox.2023.102946_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5114\/aoms.2019.84739","article-title":"Glucose fluctuation increased mesangial cell apoptosis related to AKT signal pathway","volume":"15","author":"Ying","year":"2019","journal-title":"Arch. Med. Sci. : AMS"},{"key":"10.1016\/j.redox.2023.102946_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1530\/EC-19-0234","article-title":"Increased mitochondrial fission of glomerular podocytes in diabetic nephropathy","volume":"8","author":"Ma","year":"2019","journal-title":"Endocrin. Connect."},{"key":"10.1016\/j.redox.2023.102946_bib21","doi-asserted-by":"crossref","first-page":"F494","DOI":"10.1152\/ajprenal.00297.2022","article-title":"Store-operated Ca(2+) entry inhibition ameliorates high glucose and ANG II-induced podocyte apoptosis and mitochondrial damage","volume":"324","author":"Tao","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2023.102946_bib22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.addr.2009.07.017","article-title":"PI-3-K and AKT: onto the mitochondria","volume":"61","author":"Stiles","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.redox.2023.102946_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011072","article-title":"Mechanisms of mitochondrial fission and fusion","volume":"5","author":"van der Bliek","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.redox.2023.102946_bib24","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.redox.2023.102946_bib25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.kint.2022.07.033","article-title":"Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease","volume":"102","author":"Stefansson","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.redox.2023.102946_bib26","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1172\/JCI135536","article-title":"p53\/microRNA-214\/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease","volume":"130","author":"Ma","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2023.102946_bib27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/15548627.2021.1962681","article-title":"Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2023.102946_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154334","article-title":"Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK\/SP1\/PGAM5 pathway","volume":"111","author":"Liu","year":"2020","journal-title":"Metab., Clin. Exp."},{"key":"10.1016\/j.redox.2023.102946_bib29","first-page":"677","volume":"vol. 134","author":"Gao","year":"2020"},{"key":"10.1016\/j.redox.2023.102946_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tcb.2022.03.012","article-title":"The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development","volume":"32","author":"Doke","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.redox.2023.102946_bib31","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1096\/fj.202000767R","article-title":"Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells","volume":"34","author":"Marchetti","year":"2020","journal-title":"Faseb. J. : Off. Publ. Federat.Am. Soc. Experiment. Biol."},{"key":"10.1016\/j.redox.2023.102946_bib32","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/2159-8290.CD-20-1065","article-title":"Endogenous retroelement activation by epigenetic therapy reverses the warburg effect and elicits mitochondrial-mediated cancer cell death","volume":"11","author":"Fresquet","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.redox.2023.102946_bib33","article-title":"Defects IN PINK1-PRKN-PARK7\/DJ-1-DEPENDENT mitophagy and autosomal recessive Parkinson disease","author":"Imberechts","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2023.102946_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156864","article-title":"Autosomal recessive progeroid syndrome due to homozygosity for a TOMM7 variant","author":"Garg","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2023.102946_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.kint.2022.02.038","article-title":"Reticulon-1A mediates diabetic kidney disease progression through endoplasmic reticulum-mitochondrial contacts in tubular epithelial cells","volume":"102","author":"Xie","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.redox.2023.102946_bib36","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/thno.50905","article-title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2023.102946_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2018.9","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"14","author":"Forbes","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.redox.2023.102946_bib38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db21-0983","article-title":"PACS-2 ameliorates tubular injury by facilitating endoplasmic reticulum-mitochondria contact and mitophagy in diabetic nephropathy","volume":"71","author":"Li","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2023.102946_bib39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.kint.2019.02.030","article-title":"Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis","volume":"96","author":"Barrera-Chimal","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.redox.2023.102946_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FJC.0000000000000091","article-title":"Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury","volume":"64","author":"Kolkhof","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.redox.2023.102946_bib41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/HYPERTENSIONAHA.116.08526","article-title":"Nonsteroidal mineralocorticoid receptor antagonist finerenone protects against acute kidney injury-mediated chronic kidney disease: role of oxidative stress","volume":"69","author":"Lattenist","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.redox.2023.102946_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41581-021-00490-8","article-title":"Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects","volume":"18","author":"Barrera-Chimal","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.redox.2023.102946_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13287-021-02691-1","article-title":"Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K\/AKT pathway under the hypoxia and ischemia microenvironment","volume":"13","author":"Chen","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.redox.2023.102946_bib44","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000438650","article-title":"Insulin stimulates goose liver cell growth by activating PI3K-AKT-mTOR signal pathway","volume":"38","author":"Han","year":"2016","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723003476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723003476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:33:39Z","timestamp":1761978819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723003476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"alternative-id":["S2213231723003476"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.102946","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K\/Akt\/eNOS signaling pathway in diabetic tubulopathy","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.102946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102946"}}